Karen Fahey: What If the Blood Products You Rely On Weren’t Safe?
Karen Fahey, Member of Board of Directors for the Canadian Hemophilia Society, shared Canadian Hemophilia Society‘s post on LinkedIn, adding:
”STOP and read the press release…
What if the blood products you or a loved one rely on weren’t safe — and a small community had to fight to change that?
This documentary interviews recipients of tainted blood and their families on both sides of the Atlantic.
They share heartbreaking stories of infection and the fight for health, dignity, and justice — showing incredible courage in an era of misinformation and stigma.
Today, anyone who benefits from blood transfusions or plasma-derived therapies can have confidence in the safety of the system because of their advocacy.
As a person with hemophilia who has received 17 transfusions, and someone who currently serves on the Board of Directors for the Canadian Hemophilia Society (CHS), previously served 12 years with the Quebec chapter (CHS-Qc), and has been an ambassador for CODEROUGE for 16 years, I feel a profound sense of fulfillment in supporting this mission.
Thanks to the tireless advocacy of patients and families, reforms created Canadian Blood Services and Héma-Québec — giving everyone who relies on blood products confidence in their safety.
History like this deserves to be KNOWN”
Quoting Canadian Hemophilia Society‘s post:
”Link to the CHS press release regarding a tainted blood tragedy documentary series streaming on Illico+ in Québec as of tomorrow.”
Stay updated with Hemostasis Today.
-
Feb 27, 2026, 18:30Sanjeev Saksena: From Isolated Case Reports to Clinical Evidence for Post-Ablation Myocardial Ischemia
-
Feb 27, 2026, 18:21Priya Prasad: Can Money Buy Blood?
-
Feb 27, 2026, 18:19Trulee Cardona: Hemophilia Care in Uzbekistan and Why It Matters
-
Feb 27, 2026, 18:19Bartosz Hudzik: Do Elevated Lipoprotein(a) Levels Predict Long-Term Cardiovascular Risk in Otherwise Healthy Women?
-
Feb 27, 2026, 18:14Mohamed Sikkander Abdul Razak: Factor XIa Inhibitors Show Promise With Lower Bleeding Risk
-
Feb 27, 2026, 18:09Hariom Rajput: Early Recognition and Prevention of Deep Vein Thrombosis
-
Feb 27, 2026, 17:46Perla Bandini: Whole-Exome Sequencing Unveils Suspected Primary Hemostasis Disorders
-
Feb 27, 2026, 17:44Ekaterina Balaian: Exploring Fostamatinib Use in APS Patients with Thrombocytopenia
-
Feb 27, 2026, 17:41Tagreed Alkaltham: Transfusion Reaction – Understanding Risk and Acting Early